PUBLISHER: BIS Research | PRODUCT CODE: 1484376
PUBLISHER: BIS Research | PRODUCT CODE: 1484376
Asia-Pacific Genomic Cancer Panel and Profiling Market: Focus on Application, End User, and Country - Analysis and Forecast, 2023-2033
Introduction to Asia-Pacific Genomic Cancer Panel and Profiling Market
The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023. This growth is driven by advancements in genomic research and an increasing focus on precision medicine within the field of oncology.
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2023 - 2033 |
| 2023 Evaluation | $1.56 Billion |
| 2033 Forecast | $4.78 Billion |
| CAGR | 11.81% |
Market Introduction
The Asia-Pacific (APAC) Genomic Cancer Panel and Profiling Market is experiencing significant growth, propelled by the rising incidence of cancer and the increasing adoption of personalized medicine across the region. Advances in genomic technologies and the expanding capabilities of next-generation sequencing (NGS) have enhanced the precision of cancer diagnostics and treatment strategies, catering specifically to individual genetic profiles. Governments and healthcare institutions are increasingly investing in healthcare infrastructure and genomic research, further stimulating market expansion. Moreover, collaborations between biotech firms are boosting access to advanced genomic tests. This market's growth is also supported by growing public awareness about the benefits of early cancer detection and targeted therapies, making the APAC region a vital player in the landscape of cancer genomics.
Market Segmentation
Segmentation 1: by Application
- Clinical
- Research
Segmentation 2: by End User
- Hospitals
- Clinical and Diagnostic Laboratories
- Research and Academic Institutes
- Other End Users
Segmentation 3: by Country
- China
- Japan
- India
- Australia
- South Korea
- Rest-of-Asia-Pacific
How can this report add value to an organization?
Product/Innovation Strategy: The Asia-Pacific genomic cancer panel and profiling market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers get a clear overview of the segments accounting for the largest share and the ones that are well-positioned to grow in the coming years.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.
Some of the prominent names in this market are:
- Burning Rock DX
- Genecast Biotechnology Co., Ltd
Table of Contents
Executive Summary
1 Markets
- 1.1 Product Definition
- 1.2 Inclusion and Exclusion Criteria
- 1.2.1 Inclusion Criteria
- 1.2.2 Exclusion Criteria
- 1.3 Market Scope
- 1.3.1 Scope of the Study
- 1.3.2 Key Questions Answered in this Report
- 1.4 Research Methodology
- 1.4.1 Genomic Cancer Panel and Profiling Market: Research Methodology
- 1.4.2 Data Sources
- 1.4.3 Market Estimation Model
- 1.4.4 Criteria for Company Profiling
- 1.5 Market Overview
- 1.5.1 Market Definition
- 1.5.2 Market Footprint and Growth Potential
- 1.5.3 Future Potential
2 By Region
- 2.1 Overview
- 2.2 Asia-Pacific
- 2.2.1 Key Dynamics
- 2.2.2 China
- 2.2.3 Japan
- 2.2.4 India
- 2.2.5 Australia
- 2.2.6 South Korea
- 2.2.7 Rest-of-Asia-Pacific
3 Company Profiles
- 3.1 Overview
- 3.2 Burning Rock DX
- 3.2.1 Company Overview
- 3.2.2 Role of Burning Rock DX in the Genomic Cancer Panel and Profiling Market
- 3.2.3 Business Strategies
- 3.2.4 Analyst Perspective
- 3.3 Genecast Biotechnology Co., Ltd
- 3.3.1 Company Overview
- 3.3.2 Role of Genecast Biotechnology Co., Ltd in the Genomic Cancer Panel and Profiling Market
- 3.3.3 Analyst Perspective
List of Figures
- Figure 1: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 2: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
- Figure 3: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
- Figure 4: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
- Figure 5: Genomic Cancer Panel and Profiling Market Segmentation
- Figure 6: Genomic Cancer Panel and Profiling Market: Research Methodology
- Figure 7: Primary Research Methodology
- Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
- Figure 9: Top-Down Approach (Segment-Wise Analysis)
- Figure 10: Genomic Cancer Panel and Profiling Workflow, End User Perspective
- Figure 11: Genomic Cancer Panel and Profiling Workflow, Laboratory Technician Perspective
- Figure 12: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 13: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
- Figure 14: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 15: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
- Figure 16: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
- Figure 17: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
- Figure 18: China Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
- Figure 19: Japan Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
- Figure 20: India Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
- Figure 21: Australia Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
- Figure 22: South Korea Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
- Figure 23: Rest-of-Asia-Pacific Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
- Figure 24: Genomic Cancer Panel and Profiling Market, Total Number of Companies Profiled
- Figure 25: Burning Rock DX: Product Portfolio
- Figure 26: Genecast Biotechnology Co., Ltd: Product Portfolio
List of Tables
- Table 1: Technological Trends in the Genomic Cancer Panel and Profiling Market
- Table 2: Asia-Pacific Genomic Cancer Panel and Profiling Market, Impact Analysis
